A small, ground­break­ing car­dio study push­es MyoKar­dia to a piv­otal show­down — shares soar

MyoKar­dia $MYOK has come up with the proof-of-con­cept ef­fi­ca­cy da­ta that the South San Fran­cis­co-based biotech was look­ing for in its small but po­ten­tial­ly ground­break­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER